Login

Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A. 00:10:00

Share On Facebook Share On Twitter

João Bento is the CEO of CTT Correios de Portugal, S.A.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Interlaced Ltd. Unveils AI-Driven Exploration Innovations at One-to-One Mining Investment Conference
00:10:00
Retirement Planning and Advisory Services Under PFRDA Regulations 2016
00:10:00
AeroVironment Regional Sales Manager, Jon Berry, delves into the features and capabilities of the VAPOR® all-electric Helicopter UAS.
00:10:00
Christophe Bavière on FinTech, Brexit, and the Future of Innovation | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
Plausible Tomorrows: A Conversation with Vinod Khosla | Vinod Khosla, Founder,  Khosla Ventures.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Exploring Portugal's Riches: Interview with Colt Resources CEO, Nikolas Perrault | Mr. John Gravelle - President & CEO of Colt Resources Inc.
00:10:00
Navigating Global Capital: The Role of Offshore Parallel Funds | Chris Barsness – Securities Law Specialist
00:10:00
2024 Global Market Outlook – Q3 Update: Navigating the Three-Scenario Problem
00:10:00
Self-Storage Secrets to Financial Freedom: Insights from Caley Acevez - Caley Acevez | VP of Marketing | Cedar Creek Capital
00:10:00
Behind the Scenes: American Century's Impact and the Tahoe Tournament | Jonathan Thomas, CEO , American Century Investments.
00:10:00
All Rock Minerals: Aggressively Exploring High-Grade Zinc and Copper Projects in South Australia

© 2026 Nehu